It is our great pleasure to announce that the 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics will take place in Barcelona, 18-21 November 2014. Hosted by the European Organisation for Research and Treatment of Cancer (EORTC), the National Cancer Institute (NCI) and the American Association for Cancer Research (AACR), the 2014 Symposium will bring together around 2000 academics, scientists and pharmaceutical industry representatives from across the globe to discuss innovations in drug development, target selection and the impact of new discoveries in molecular biology.
This symposium is unique: it is THE scientific forum for developing drugs for the future! As a one-of-a-kind Symposium at the forefront of drug development, it will enable participants to apply the latest findings and knowledge in their work and practice. This edition will also build on the success of the previous symposium which was widely praised for the quality of its programme, inspirational contributions and exclusive insights.
Follow the latest updates about the 26th EORTC-NCI-AACR SYMPOSIUM on Twitter using #ENA2014